Brady Corp executive option exercises and share sales on Form 4
Rhea-AI Filing Summary
Brady Corp (BRC) reported an insider equity transaction by its President - EMEA & Australia on a Form 4. On 11/19/2025, the officer exercised multiple stock options for Class A Common Stock at exercise prices of $43.98, $54.05, $39.92 and $49.79, receiving the same number of shares in each case.
On the same date, the officer sold matching blocks of 1,183, 2,882, 3,563 and 3,266 Class A Common shares at weighted average sale prices of about $74–$75 per share, with detailed price ranges disclosed for each group of trades. After these option exercises and related sales, the officer directly owned 7,672 shares of Brady Corp Class A Common Stock.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did Brady Corp (BRC) disclose on this Form 4?
The filing shows the President - EMEA & Australia of Brady Corp exercised multiple stock options for Class A Common Stock on 11/19/2025 and sold the corresponding shares on the same date.
How many Brady Corp (BRC) shares did the officer sell in this Form 4?
The officer sold blocks of 1,183, 2,882, 3,563 and 3,266 Class A Common shares, each corresponding to an option exercise reported for 11/19/2025.
What sale prices were reported for the Brady Corp (BRC) insider trades?
The sales were reported at weighted average prices of $74.82, $74.79, $74.22 and $74.24 per share, with underlying trades in ranges from $74.12 to $75.21, as detailed in the footnotes.
How many Brady Corp (BRC) shares does the reporting person own after the transactions?
Following the option exercises and related sales on 11/19/2025, the officer directly owned 7,672 shares of Brady Corp Class A Common Stock.
What were the exercise prices of the Brady Corp (BRC) stock options involved?
The stock options were exercised at prices of $43.98, $54.05, $39.92 and $49.79 per share for Class A Common Stock.
How were the Brady Corp (BRC) stock options structured before exercise?
The footnotes state the options represented shares that became exercisable in three equal installments, one third each year for the three years following the grant date, with expiration dates ranging from 09/25/2028 to 09/16/2031.